# CHN1

## Overview
The CHN1 gene encodes the protein α2-chimaerin, a Rac-specific GTPase-activating protein (GAP) that plays a pivotal role in neuronal signaling and cytoskeletal dynamics. As a member of the GAP family, α2-chimaerin is involved in the inactivation of Rac1, a small GTPase, thereby influencing processes such as axon guidance and cell migration. The protein is characterized by several functional domains, including a C1 domain, a Rac-GAP domain, and an Src homology 2 (SH2) domain, which facilitate its interactions and regulatory functions (Caloca2008Role). Mutations in CHN1 have been linked to congenital disorders such as Duane retraction syndrome and Moebius syndrome, highlighting its clinical significance in cranial nerve development (Zhou2020Identification; MansoBazús2024Case). Additionally, CHN1 expression levels have implications in cancer prognosis, suggesting its potential as a biomarker and therapeutic target (Li2021Bioinformaticsbased).

## Structure
The CHN1 gene encodes the α2-chimaerin protein, which is a Rac-specific GTPase-activating protein (GAP) involved in neuronal signaling. The protein structure includes several key domains: a C1 domain, a Rac-GAP domain, and an Src homology 2 (SH2) domain. The C1 domain is responsible for binding diacylglycerol (DAG) and is involved in the regulation of protein translocation and activity (Caloca2008Role). The Rac-GAP domain is crucial for the inactivation of Rac1, a member of the Rho family of GTPases, which plays a significant role in cellular signaling pathways (Caloca2008Role).

The α2-chimaerin protein undergoes post-translational modifications, such as phosphorylation, which can affect its function and localization. The p.(Phe213Val) variant, identified in the CHN1 gene, is located in the C1 domain and affects the protein's stability and tertiary structure by altering hydrogen bonding and causing conformational changes (Zhou2020Identification). This variant also impacts the protein's response to phorbol-myristoyl acetate (PMA), enhancing membrane translocation (Zhou2020Identification).

Alternative splicing of the CHN1 gene can produce different isoforms, potentially influencing the protein's function and cellular localization (Ip2011α2chimaerin).

## Function
The CHN1 gene encodes the protein α2-chimaerin, a Rac GTPase-activating protein (RacGAP) that plays a crucial role in regulating cytoskeletal dynamics by inactivating Rac1, a small GTPase involved in various cellular processes. In healthy human cells, α2-chimaerin exists in an autoinhibited form and is activated by upstream signaling, leading to the hydrolysis of Rac-GTP to inactive Rac-GDP. This process is essential for altering actin dynamics, which can cause growth cone collapse, a critical event for axon guidance during neurodevelopment (Nugent2017Mutant).

α2-Chimaerin is expressed in nearly all central and peripheral developing neurons, particularly in regions like rhombomere 5, where abducens neurons are located. It acts downstream of several receptors implicated in axon growth and guidance, including EPH receptor A4 (EphA4) and TrkB, and is essential for the proper development of the ocular motor system, which includes the oculomotor, trochlear, and abducens cranial nerves (Nugent2017Mutant).

In T-cells, α2-chimaerin modulates Rac1 activity, which is crucial for T-cell receptor signaling. It functions as a negative regulator of NF-AT activity, a key transcription factor in T-cell activation and differentiation, by reducing active Rac1 levels (Caloca2008Role).

## Clinical Significance
Mutations and alterations in the CHN1 gene are associated with several congenital disorders, primarily affecting ocular motility. Duane retraction syndrome (DRS) is a well-documented condition linked to CHN1 mutations. DRS is characterized by restricted eye movement due to abnormal development of the sixth cranial nerve, leading to symptoms such as globe retraction and limited horizontal eye movement. Specific variants, such as p.(Phe213Val), have been identified in families with DRS, suggesting a pathogenic role by altering the protein's function and stability (Zhou2020Identification).

CHN1 mutations have also been implicated in Moebius syndrome (MBS), a rare congenital neurological disorder marked by facial nerve paralysis and ocular abduction impairment. A novel variant, p.Gly215Arg, was identified in a patient with MBS, indicating that CHN1 may contribute to a spectrum of cranial dysinnervation syndromes (MansoBazús2024Case).

In gastric cancer, CHN1 overexpression is associated with poor prognosis and may influence immune cell infiltration and the effectiveness of immunotherapy. This suggests that CHN1 could serve as a biomarker for cancer progression and a potential therapeutic target (Li2021Bioinformaticsbased).

## Interactions
CHN1, also known as chimerin 1, encodes a GTPase-activating protein that interacts with several proteins, playing a crucial role in signal transduction and neuronal development. One of its primary interactions is with Rac1, a small GTPase involved in regulating cytoskeletal dynamics. CHN1 enhances Rac-GAP activity, which inactivates Rac1, thereby influencing processes such as cell migration and axon guidance (Zhou2020Identification; Caloca2008Role).

In the context of Duane Retraction Syndrome (DRS), CHN1 mutations, particularly in α2-chimaerin, have been shown to interact with ephrin signaling pathways, specifically involving EphA4. This interaction is crucial for the development of the abducens nerve, with mutant α2-chimaerin affecting neuron growth downstream of these pathways (Nugent2017Mutant). The study suggests that α2-chimaerin may also interact with other signaling pathways, such as BDNF/TrkB and semaphorin/plexin/neuropilin, indicating its involvement in complex axon guidance mechanisms (Nugent2017Mutant).

CHN1's role extends to T-cell receptor signaling, where α2- and β2-chimaerin modulate NF-AT activity, a critical pathway for T-cell activation. These proteins act as negative regulators, with their GTPase-activating domain being essential for this inhibitory function (Caloca2008Role).


## References


[1. (MansoBazús2024Case) Carmen Manso-Bazús, Nino Spataro, Elisabeth Gabau, Viviana P. Beltrán-Salazar, Juan Pablo Trujillo-Quintero, Nuria Capdevila, Anna Brunet-Vega, Neus Baena, A Arockia Jeyaprakash, Victor Martinez-Glez, and Anna Ruiz. Case report: identification of a novel variant p.gly215arg in the chn1 gene causing moebius syndrome. Frontiers in Genetics, January 2024. URL: http://dx.doi.org/10.3389/fgene.2024.1291063, doi:10.3389/fgene.2024.1291063. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2024.1291063)

[2. (Ip2011α2chimaerin) Jacque P K Ip, Lei Shi, Yu Chen, Yasuhiro Itoh, Wing-Yu Fu, Andrea Betz, Wing-Ho Yung, Yukiko Gotoh, Amy K Y Fu, and Nancy Y Ip. Α2-chimaerin controls neuronal migration and functioning of the cerebral cortex through crmp-2. Nature Neuroscience, 15(1):39–47, December 2011. URL: http://dx.doi.org/10.1038/nn.2972, doi:10.1038/nn.2972. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nn.2972)

[3. (Caloca2008Role) María José Caloca, Pilar Delgado, Balbino Alarcón, and Xosé R. Bustelo. Role of chimaerins, a group of rac-specific gtpase activating proteins, in t-cell receptor signaling. Cellular Signalling, 20(4):758–770, April 2008. URL: http://dx.doi.org/10.1016/j.cellsig.2007.12.015, doi:10.1016/j.cellsig.2007.12.015. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2007.12.015)

[4. (Zhou2020Identification) Tai-Cheng Zhou, Wen-Hua Duan, Xiao-Lin Fu, Qin Zhu, Li-Yun Guo, Yuan Zhou, Zhi-Juan Hua, Xue-Jiao Li, Dong-Mei Yang, Jie-Ying Zhang, Jie Yin, Xiao-Fan Zhang, Guang-Long Zhou, and Min Hu. Identification of a novel chn1 p.(phe213val) variant in a large han chinese family with congenital duane retraction syndrome. Scientific Reports, October 2020. URL: http://dx.doi.org/10.1038/s41598-020-73190-1, doi:10.1038/s41598-020-73190-1. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-73190-1)

[5. (Nugent2017Mutant) Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, and Elizabeth C. Engle. Mutant α2-chimaerin signals via bidirectional ephrin pathways in duane retraction syndrome. Journal of Clinical Investigation, 127(5):1664–1682, March 2017. URL: http://dx.doi.org/10.1172/jci88502, doi:10.1172/jci88502. This article has 25 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci88502)

[6. (Li2021Bioinformaticsbased) Jie-Pin Li, Shu-Hong Zeng, Yong-Hua Zhang, and Yuan-Jie Liu. Bioinformatics-based analysis of the association between the a1-chimaerin ( chn1 ) gene and gastric cancer. Bioengineered, 12(1):2874–2889, January 2021. URL: http://dx.doi.org/10.1080/21655979.2021.1940621, doi:10.1080/21655979.2021.1940621. This article has 4 citations.](https://doi.org/10.1080/21655979.2021.1940621)